Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Rang in Aktien #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Aktienkurs
$12.18
Zuletzt synchronisiert: 2025-02-17
Marktkapitalisierung
$1.49B
Veränderung (1 Tag)
4.21%
Veränderung (1 Jahr)
0.00%
Land
IN
Handel Glenmark Life Sciences Limited (GLS)

Kategorie

Kursverlauf für Glenmark Life Sciences Limited (GLS)
Höchster Schlusskurs: $13.07 am 2025-02-01

Niedrigster Schlusskurs: $9.63 am 2021-08-01
Kursverlauf der Aktie von Glenmark Life Sciences Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 8.46%
2024 56.27%
2023 49.21%
2022 -36.04%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.82 32.07%
DE
$37.84 25.57%
JP
$223.37 28.13%
CH
$21.19 17.04%
IN